University Of Oxford
- Address
- Boundary Brook House, Churchill Drive, Headington
Sponsor Overview
Specializations
Infectious Disease Research
The University of Oxford supports clinical research in infectious diseases with a focus on monkeypox virus disease and pneumonia, addressing both emerging viral infection and severe respiratory illness.
- Monkeypox virus disease
- Pneumonia
- Viral infection
- Respiratory disease
Its trial portfolio includes studies of clinical outcomes in patients with mpox and investigations in hospital-based care for patients with pneumonia.
Hospital Medicine and Acute Care
Clinical activity includes research on outcomes relevant to hospitalised patients, with attention to mortality and time to discharge in acute illness settings.
- Mortality
- Time to discharge
- Hospital care
- Acute illness
These studies reflect an interest in clinical endpoints that are directly relevant to inpatient management and recovery.
Antiviral and Therapeutic Outcomes
Research funded by the sponsor examines outcomes in patients treated and not treated with tecovirimat and other antiviral drugs, with emphasis on treatment-related clinical course in mpox.
- Tecovirimat
- Antiviral therapy
- Treatment outcomes
- Clinical course
The therapeutic focus is centred on understanding how antiviral management relates to patient outcomes in monkeypox virus disease.
Multinational Clinical Collaboration
The sponsor’s research spans 11 countries through a network of 122 collaborating research sites, supporting coordinated study of infectious disease outcomes across diverse clinical settings.
- International research sites
- Collaborative studies
- Cross-country recruitment
- Clinical outcome assessment
This footprint supports work in both pneumonia and mpox across multiple healthcare environments.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| A Double‑Blind Randomized Controlled Trial of Oral Cannabidiol Augmentation of Antipsychotic Therapy in First‑Episode Psychosis |  Austria Germany Greece Italy Spain The Netherlands | Not Yet Recruiting |
| Cohort study of human mpox virus disease |  Belgium France Ireland Italy Norway Portugal Spain The Netherlands | Not Recruiting |
| Evaluation of Dexamethasone, Hydrocortisone, Prednisolone, and Oseltamivir in the Treatment of Pneumonia in Hospitalized Patients | Belgium Estonia France Italy Portugal Romania Spain Sweden The Netherlands | Recruiting |
Data & Insights
This sponsor works with 8 molecules, of which 0 are not being studied by other sponsors.
This sponsor has worked with 124 sites across their trial portfolio.
Therapeutic Focus
- 1.Virus Diseases2 trials182 other sponsors
- 2.Bacterial Infections and Mycoses1 trial180 other sponsors
- 3.Mental Disorders1 trial150 other sponsors
- 4.Respiratory Tract Diseases1 trial277 other sponsors
Partnered Research Centres
124 centres- Address
- Sykehusveien 25, 1474 Lorenskog
- Address
- Molengracht 21, 4818 CK Breda
- Address
- De Boelelaan 1117, 1081 HV Amsterdam
- Address
- Meibergdreef 9, 1105 AZ Amsterdam
- Address
- Piazza Santa Maria Di Gesu, 95123 Catania
- Address
- 46 Rue Henri Huchard, 75877 Paris
Want to get in touch with this sponsor?
Send a question and we'll pass it on to University Of Oxford.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.